AI & Machine Learning

Alibaba's Accio Work deploys AI "business teams" to SMEs, managing e-commerce and even launching physical products from scratch for a new era of business.

As cargo capacity shrinks and tensions rise, FedEx leverages new routes and digital tools to keep critical medical supplies moving across the Middle East.

A new partnership will allow consumers to spend stablecoins and Bitcoin at 175M+ locations, blurring the lines between digital wallets and everyday commerce.

Snap CEO Evan Spiegel will headline Augmented World Expo, unveiling new tools from subsidiary Specs Inc. and charting a course for human-empowered spatial AI.

The largest deal in epigenetic testing sees TruDiagnostic's parent buy Dr. David Sinclair's Tally Health, aiming to make personalized longevity mainstream.

NBA star Russell Westbrook's new ad tech platform aims to revolutionize marketing by putting authentic cultural intelligence at the core of its strategy.

A new report shows most procurement and IT teams collaborate, but a failure on AI governance is stalling deployment and creating enterprise-wide risk.

With huge energy needs, Israel's water company Mekorot turns to nT-Tao's fusion tech in a bold move that could redefine national infrastructure resilience.

As AI and usage-based pricing complicate finance, BillingPlatform launches RevVenue, an expert-led hub to help firms navigate a new era of compliance risk.

With new sensors that defy magnetic interference and a key investment from Plug and Play, XELA Robotics is set to revolutionize industrial automation in America.

With staggering 34% revenue growth, United Imaging is leveraging R&D and global expansion to disrupt the Western-dominated medical imaging market.

Brookfield Infrastructure reports a 10% FFO jump, fueled by a 46% surge in its data segment and a $1B capital recycling push, as it mulls a unified structure.

New GovTech firm LexiPoint, backed by Summit, launches a platform to turn complex regulations into auditable, consistent, and AI-governable decisions.

Shanghai's Vivacta Bio raises over $50M from top VCs to revolutionize cancer treatment with its pioneering in vivo CAR-T therapy, GT801.

Italian AI firm ELAI expands to the US, appointing veteran Kjersten Moody to help companies finally get real business results from their AI spend.

A new campaign aims to save a major research hub, igniting a debate over its economic benefits, medical breakthroughs, and the future of animal testing.

The company's Stevie® Awards highlight a critical truth: as AI strains enterprise systems, a robust, automated network is no longer optional.

A new patent for a biomarker-guided therapy offers hope for millions with treatment-resistant depression and extends market exclusivity for decades.

MindBio's new tech detects intoxication from your voice, promising safer workplaces but sparking major debate over surveillance, bias, and data privacy.

As NVIDIA's NemoClaw stack makes AI agents deployable, Quali's Torque platform adds the critical governance layer for enterprise-scale security and cost control.